The IR Department Podcast
We are a boutique Investor Relations and Public Relations Company representing some of Australia’s most exciting emerging companies. We are creating a regular podcast series outlining current news and future developments.
Listen on:
Episodes
Tuesday Sep 13, 2022
Tuesday Sep 13, 2022
We speak with Uniseed CEO, Peter Devine, about the current ESG investment landscape, their recent collaboration with UniSuper and an unusual passion.
Monday Aug 29, 2022
Monday Aug 29, 2022
We talk to Race Oncology's CSO, Dr Daniel Tillett, about the early days of Race, the progress that the Company has made with its drug Zantrene®, and what success could mean for the future landscape of cancer treatments.
Monday Jun 27, 2022
Monday Jun 27, 2022
Our Communications Director, Cherie Hartley, talks with AdAlta's CEO & M.D. Dr Tim Oldham, who takes us inside the mind of a biotech company. He discussed the importance of focus for a platform company, explains why making decisions on a day-to-day basis is so crucial for risk reduction and why they're investing in supporting core strategies as well as their target product profile.
Behind the Numbers
We present a series of podcasts granting you unique access into the minds of the visionaries behind some of Australia's most exciting ASX-listed Companies.
We discuss what the future holds for some potentially world-changing research and development, their aspirations and commitment to the future along with in-depth insight into the passions and commitment involved to revolutionise the future.